Jump Financial, LLC Adicet Bio, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$2.13 - $7.13 $38,838 - $130,008	18,234 Added 44.15%	59,534 $144,000
Q2 2023 Aug 07, 2023	BUY	$2.13 - $7.13 $38,838 - $130,008	18,234 Added 44.15%	59,534 $144,000
Q1 2023 Oct 21, 2024	BUY	$5.52 - $9.23 $227,975 - $381,199	41,300 New	41,300 $237,000
Q1 2023 May 03, 2023	BUY	$5.52 - $9.23 $227,975 - $381,199	41,300 New	41,300 $237,000
Q2 2022 Aug 09, 2022	SELL	$10.26 - $20.81 $120,144 - $243,685	-11,710 Reduced 50.04%	11,690 $171,000
Q1 2022 May 12, 2022	SELL	$11.53 - $19.97 $141,819 - $245,631	-12,300 Reduced 34.45%	23,400 $467,000
Q4 2021 Feb 10, 2022	BUY	$7.37 - $17.49 $263,109 - $624,393	35,700 New	35,700 $624,000
Q3 2021 Nov 12, 2021	SELL	$6.29 - $9.93 $83,657 - $132,069	-13,300 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$9.19 - $15.93 $122,227 - $211,869	13,300 New	13,300 $137,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.